Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432 = Lyse de cellules fraîches de tumeur humaine par des lymphocytes autologues du sang périphérique et des lymphocytes d'épanchement pleural activés par OK 432UCHIDA, A; MICKSCHE, M.Journal of the National Cancer Institute. 1983, Vol 71, Num 4, pp 673-680, issn 0027-8874Article

Irinotecan enhances IL-12 production by OK-432-activated murine macrophagesBIN ZHANG; FUJIMOTO, Toshihiro; KANEDA, Atsuko et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2499-2504, issn 0250-7005, 6 p.Article

Vaccination With OK-432 Followed by TC-I Tumor Lysate Leads to Significant Antitumor EffectsCHEN, I-Ju; YEN, Chih-Feng; LIN, Kun-Ju et al.Reproductive sciences (Thousand Oaks, Calif.). 2011, Vol 18, Num 7, pp 687-694, issn 1933-7191, 8 p.Article

Fetal OK-432 pleurodesis : complete or incomplete?CHEN, M; SHIH, J. C; WANG, B. T et al.Ultrasound in obstetrics & gynecology. 2005, Vol 26, Num 7, pp 791-793, issn 0960-7692, 3 p.Article

CLINICAL EXPERIENCES WITH THE STREPTOCOCCAL ANTICANCER PREPARATION, OK-432 (NSC-B116209) = EXPERIENCES CLINIQUES AVEC LA PREPARATION ANTICANCEREUSE D'ORIGINE STREPTOCOCCIQUE, OK-432 (NSC-B116209)1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 2; PP. 211-220; BIBL. 7REF.Serial Issue

Intrauterine Treatment of Large Fetal Neck Lymphangioma with OK-432MIKOVIC, Zeljko; SIMIC, Radoje; EGIC, Amira et al.Fetal diagnosis and therapy. 2009, Vol 26, Num 2, pp 102-106, issn 1015-3837, 5 p.Article

A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax : possible correlation with poor response to fetal therapyMA, Gwo-Chin; LIU, Chin-San; CHANG, Shun-Ping et al.Prenatal diagnosis. 2008, Vol 28, Num 11, pp 1057-1063, issn 0197-3851, 7 p.Article

Intrauterine therapy for the acutely enlarging fetal cystic hygromaKUWABARA, Yoshimitsu; SAWA, Rintaro; OTSUBO, Yasuo et al.Fetal diagnosis and therapy. 2004, Vol 19, Num 2, pp 191-194, issn 1015-3837, 4 p.Article

Experimental treatment of bilateral fetal chylothorax using in-utero pleurodesisYANG, Y.-S; MA, G.-C; CHEN, M et al.Ultrasound in obstetrics & gynecology. 2012, Vol 39, Num 1, pp 56-62, issn 0960-7692, 7 p.Article

IDENTIFICATION OF A SERUM GLYCOPROTEIN THAT INCREASED IN OK-432-TREATED MICE AS HEMOPEXINTORIKAI T; ITOH O; SATOH M et al.1981; GANN; ISSN 0016-450X; JPN; DA. 1981; VOL. 72; NO 1; PP. 92-97; BIBL. 19 REF.Article

Reduction of pleural effusion by OK-432 in a fetus complicated with congenital hydrothoraxTSUKIHARA, Ayumi; TANEMURA, Mitsuyo; SUZUKI, Yoshikatsu et al.Fetal diagnosis and therapy. 2004, Vol 19, Num 4, pp 327-331, issn 1015-3837, 5 p.Article

Successful Treatment of Severe Fetal Chylothorax Resistant to Repeated Pleuroamniotic Shunting by OK-432 PleurodesisLO, T. K; LAU, W. L; LAM, Y. Y et al.Fetal diagnosis and therapy. 2012, Vol 31, Num 4, pp 260-263, issn 1015-3837, 4 p.Article

Treatment of branchial cleft cyst with intracystic injection of OK-432ROH, Jong-Lyel; SUNG, Myung-Whun; KWANG HYUN KIM et al.Acta oto-laryngologica. 2006, Vol 126, Num 5, pp 510-514, issn 0001-6489, 5 p.Article

Sclerosing treatment of lymphangiomas with OK-432LUZZATTO, C; MIDRIO, P; TCHAPRASSIAN, Z et al.Archives of disease in childhood. 2000, Vol 82, Num 4, pp 316-318, issn 0003-9888Article

Interferon-α in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agentsKANETO, E; SASAKI, H; TAMURA, I et al.Biken journal. 1983, Vol 26, Num 2, pp 99-102, issn 0006-2324Article

Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalisMING CHEN; CHEN, Chih-Ping; SHIH, Jin-Chung et al.Fetal diagnosis and therapy. 2005, Vol 20, Num 4, pp 309-315, issn 1015-3837, 7 p.Article

STREPTOCOCCAL PREPARATION AS AN ACTIVATOR OF HOST-MEDIATED IMMUNE RESPONSE: CELLULAR IMMUNITY AND ALTERNATE PATHWAY OF COMPLEMENTKONDO M; IKEZAKI M; MINANISHI H et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 6; PP. 675-678; BIBL. 11 REF.Article

Adjuvant immunotherapy: two randomized controlled studies of patients with cervical cancerOKAMURA, K; HAMAZAKI, Y; YAJIMA, A et al.Biomedicine & pharmacotherapy. 1989, Vol 43, Num 3, pp 177-181, issn 0753-3322Article

INHIBITORY EFFECT OF A STREPTOCOCCAL PREPARATION (OK-432) ON INDUCTION OF SPLENOMEGALY BY FRIEND LEUKEMIA VIRUS. = EFFET INHIBITEUR D'UNE PREPARATION DE STREPTOCOQUES OK-432) SUR L'INDUCTION D'UNE SPLENOMEGALIE PAR LE VIRUS DE LA LEUCEMIE DE FRIENDSUZUKI S; YAMAMOTO A; OGAWA H et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 4; PP. 455-456; BIBL. 5 REF.Article

Enhancement of antitumor activity of OK-432 (Picibanil) by Triton X-114 phase partitioningHASHIMOTO, Masahito; TAKASHIGE, Katsuhiro; MORIYA, Yoichiro et al.International immunopharmacology. 2008, Vol 8, Num 1, pp 12-19, issn 1567-5769, 8 p.Article

Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in childrenOGITA, S; TSUTO, T; TOKIWA, K et al.British journal of surgery. 1987, Vol 74, Num 8, pp 690-691, issn 0007-1323Article

STUDIES ON THE PROPERTIES OF A STREPTOCOCCAL PREPARATION OK-432 (NSC-B116209) AS AN IMMUNOPOTENTIATOR. I. ACTIVATION OF SERUM COMPLEMENT COMPONENTS AND PERITONEAL EXUDATE CELLS BY GROUP A SREPTOCOCCUSNATSU UMESAKAI S; RYOYAMA K; KOSHIMURA S et al.1976; JAP. J. EXP. MED.; JAP.; DA. 1976; VOL. 46; NO 2; PP. 123-133; BIBL. 1 P. 1/2Article

Acute Behavioral Effects of Intrapleural OK-432 (Picibanil) Administration in Preterm Fetal SheepCOWIE, Rosalind V; STONE, Peter R; PARRY, Emma et al.Fetal diagnosis and therapy. 2009, Vol 25, Num 3, pp 304-313, issn 1015-3837, 10 p.Article

Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children?HALL, Nigel; ADE-AJAYI, Niyi; BREWIS, Clive et al.Surgery. 2003, Vol 133, Num 3, pp 238-242, issn 0039-6060, 5 p.Article

Recurrent plunging ranula treated with OK-432WOO, Jeong-Su; SOON JAE HWANG; LEE, Heung-Man et al.European archives of oto-rhino-laryngology. 2003, Vol 260, Num 4, pp 226-228, issn 0937-4477, 3 p.Article